About Quagen Pharma India Private Limited
Data last updated:
Quagen Pharma India Private Limited is a foreign private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Quagen Pharmaceuticals Llc. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74900AP2015FTC096297. Its GSTIN is 37AAACQ3754E1ZI (Andhra Pradesh).
The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹32.44 Cr. It is led by directors Ashish Arunkumar Shah (Managing Director) and Narsinh Keshar Desai.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Visakhapatnam, Andhra Pradesh.
As per the financials filed for FY 2018, the company reported a revenue of ₹3.87 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net loss of ₹65.18 Lakh and EBITDA of -₹81.62 Lakh.
The company has about 4 employees on its provident fund (EPFO) records.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website dmrao.com.
Company details
Contact details
Quagen Pharma India Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressR & D Building Ground Floor Ramky Pharmacity Commercial Hub Junction Pharma City Pa, Rawada, Visakhapatnam, Andhra Pradesh, India – 530019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Quagen Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Quagen Pharma India Private Limited
FY 2018 filings availableQuagen Pharma India Private Limited reported revenue of ₹3.87 Lakh (up 6% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year. EBITDA rose 78% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹3.87 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹81.62 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹65.18 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Quagen Pharma India Private Limited, buy the company report.
Board of directors of Quagen Pharma India Private Limited
Quagen Pharma India has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narsinh Keshar Desai | Director | 21 Apr 2015 | 11 Years 6 Months | Current |
| Ashish Arunkumar Shah Also directs: Areva Synthetics Private Limited | Managing Director | 26 Mar 2015 | 11 Years 7 Months | Current |
Peer comparison
Quagen Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biosoilz India Private Limited | ₹3.95 Lakh (FY 2025) | 56.0% | Vanastalipuram, Telangana, India | |||
| Savicure Remedies Private Limited | ₹3.94 Lakh (FY 2020) | New Delhi, Delhi, India | ||||
| Nutriley Pharmaceuticals Private Limited | ₹3.92 Lakh (FY 2025) | 1510.0% | Hisar, Haryana, India | |||
| Rexoby Pharmaceutical Private Limited | ₹3.89 Lakh (FY 2024) | -68.0% | Noida, Uttar Pradesh, India | |||
| Pdanil Healthcare Private Limited | ₹3.88 Lakh (FY 2024) | -39.0% | Agra, Uttar Pradesh, India | |||
| Quagen Pharma India Private Limitedthis company | ₹3.87 Lakh (FY 2018) | -₹65.18 Lakh | 6.0% | 4 | Visakhapatnam, Andhra Pradesh, India | |
| Rxsalvino Pharmaceuticals Private Limited | ₹3.87 Lakh (FY 2021) | -58.0% | Navi Mumbai, Maharashtra, India | |||
| Nathan Pharma Private Limited | ₹3.87 Lakh (FY 2024) | Baddi, Himachal Pradesh, India | ||||
| Phyto Medicines Ltd. | ₹3.84 Lakh (FY 2025) | 151.0% | Kolkata, West Bengal, India | |||
| Version2 Healthcare India Private Limited | ₹3.83 Lakh (FY 2025) | -32.0% | Mission Road, Karnataka, India | |||
| Long Life Pharmaceuticals Private Limited | ₹3.82 Lakh (FY 2019) | -44.0% | New Delhi, Delhi, India |
To see the full peer comparison of Quagen Pharma India Private Limited, buy the company report.
Auditor
Quagen Pharma India Private Limited is audited by D M RAO & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D M RAO & CO | FY 2018 | 006995S |
Shareholding
The shareholding of Quagen Pharma India Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Quagen Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Quagen Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Quagen Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Quagen Pharma India Private Limited has a workforce of 4 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
Quagen Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAACQ3754E1ZI | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Quagen Pharma India Private Limited, buy the company report.
Recent activity
Quagen Pharma India Private Limited has 7 board changes on record since 2015: 3 appointments and 4 cessations. The latest: Srikanth Dandamudi ceased to be Director on 06 Sep 2024.
Frequently asked questions
Quagen Pharma India is an active foreign private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 March 2015 (11+ years old) and is registered under CIN U74900AP2015FTC096297.
Quagen Pharma India has 2 current directors:
- Ashish Arunkumar Shah - Managing Director
- Narsinh Keshar Desai - Director
The latest financial statements of Quagen Pharma India on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
The GSTIN of Quagen Pharma India is 37AAACQ3754E1ZI, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Quagen Pharma India is U74900AP2015FTC096297. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quagen Pharma India was incorporated on 10 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Quagen Pharma India by revenue are Biosoilz India Private Limited, Savicure Remedies Private Limited, Nutriley Pharmaceuticals Private Limited, Rexoby Pharmaceutical Private Limited, Pdanil Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Srikanth Dandamudi ceased to be Director on 06 Sep 2024. Rimpy Choudhury was appointed as Company Secretary on 15 Dec 2019. Ashish Arunkumar Shah ceased to be Director on 30 Apr 2015. Quagen Pharma India has 7 board changes on record in total.
Quagen Pharma India can be reached through the website dmrao.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The registered office of Quagen Pharma India is at R & D Building Ground Floor Ramky Pharmacity Commercial Hub Junction Pharma City Pa, Rawada, Visakhapatnam, Andhra Pradesh, India – 530019.
Quagen Pharma India operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
